The assessment of cancer risk is a complex process that requires the examination of etiological agents, real-world environments, and individual rates of exposure. This reference offers practical approaches to determine cancer risk in individuals, groups of exposed persons, and the general public in relation to individual genetic and acquired susceptibilities.

This volume comprises the investigation of factors that may predict the response to treatment, outcome, and survival by exploring:

design considerations in molecular epidemiology, including:

• case-only
• family-based
• approaches for evaluation of genetic susceptibility to exposure and addiction pharmacogenetics
• incorporation of biomarkers in clinical trials

measurement issues in molecular epidemiology, including

• DNA biosampling methods
• principles for high-quality genotyping
• haplotypes
...